Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beauty Health (SKIN) Cash from Operations (2020 - 2025)

Beauty Health (SKIN) has disclosed Cash from Operations for 6 consecutive years, with 9647000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Cash from Operations fell 6.48% to 9647000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was 38761000.0, a 803.72% increase, with the full-year FY2024 number at 16134000.0, down 25.82% from a year prior.
  • Cash from Operations was 9647000.0 for Q3 2025 at Beauty Health, roughly flat from 9646000.0 in the prior quarter.
  • In the past five years, Cash from Operations ranged from a high of 21966000.0 in Q2 2023 to a low of 38471000.0 in Q1 2022.
  • A 5-year average of 3936210.53 and a median of 1261000.0 in 2021 define the central range for Cash from Operations.
  • Peak YoY movement for Cash from Operations: skyrocketed 55285.19% in 2021, then tumbled 10637.25% in 2022.
  • Beauty Health's Cash from Operations stood at 3279000.0 in 2021, then tumbled by 264.47% to 5393000.0 in 2022, then increased by 4.13% to 5170000.0 in 2023, then skyrocketed by 418.61% to 16472000.0 in 2024, then plummeted by 41.43% to 9647000.0 in 2025.
  • Per Business Quant, the three most recent readings for SKIN's Cash from Operations are 9647000.0 (Q3 2025), 9646000.0 (Q2 2025), and 2996000.0 (Q1 2025).